Researchers at MIT, Harvard launch start-up that will focus on combination medicines

Blend Therapeutics announced its launch as a Watertown biotechnology company that aims to focus on so-called “combination medicines.” Company founders include Robert Langer, HMS senior lecturer on surgery and David H. Koch Institute Professor at the Massachusetts Institute of Technology, and Omid Farokhzad, HMS associate professor of anesthesia at Brigham and Women's Hospital.

Read full article